Can-Fite BioPharma Ltd.
CANFAMEXHealthcare● Active
$3.08
+$0.00(+0.00%)
Market Cap$1657040
P/E Ratio—
52W High$23.4
52W Low$2.83
Can-Fite BioPharma Ltd. (CANF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CANF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($9.91M) | ($7.88M) | ($7.63M) | ($10.17M) | ($12.62M) |
| Depreciation & Amort. | $0.02M | $0.01M | $0.01M | $0.01M | $0.01M |
| Stock-Based Comp. | $0.00M | $0.36M | $0.26M | $0.26M | $0.47M |
| Change in Working Capital | $0.44M | ($0.27M) | ($0.94M) | ($1.30M) | $2.43M |
| Net Cash from Operations | ($9.02M) | ($7.64M) | ($8.44M) | ($10.80M) | ($9.86M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00M) | ($0.01M) | ($0.00M) | ($0.01M) | ($0.01M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | ($14.50M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.00M) | $1.50M | $0.50M | $9.50M | ($14.51M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $9.72M | $6.71M | $9.14M | $0.00M | $20.46M |
| Free Cash Flow | |||||
| Free Cash Flow | ($9.02M) | ($7.64M) | ($8.44M) | ($10.81M) | ($9.87M) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Can-Fite BioPharma Ltd. data
About Can-Fite BioPharma Ltd. (CANF) Cash Flow Statement
Can-Fite BioPharma Ltd. generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -2210.13%. Capital expenditure was ($0.00B).
Frequently asked questions
CANF · 4 questionsCan-Fite BioPharma Ltd. generated free cash flow of ($0.01B) for 2025, down 18.1% year-over-year.
CANF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10